Plain-English translation of NCT04767568 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are developing a blood test to help identify colorectal cancer in patients who either have signs of bleeding or have already been diagnosed. The goal is to find a faster way to identify which patients need urgent treatment, especially during times when hospitals are overwhelmed and colonoscopy procedures are delayed.
Colorectal cancer is common and increasing, and early detection saves lives. However, during emergencies like the COVID-19 pandemic, diagnostic procedures get delayed, which can harm patients. This blood test could help doctors quickly prioritize which patients need the most urgent care.
You likely qualify if…
You likely don't qualify if…
Participation is straightforward: you will have a blood sample drawn as part of this study. Depending on which group you join, this might happen at the time of your screening test results, or before your planned colorectal cancer surgery. The blood sample will be tested to see if it can help doctors identify colorectal cancer quickly.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment target
~400 participants
Started
March 2021
Primary completion
August 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christophe BORG, Pr
Centre Hospitalier Universitaire de Besancon
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.